Investing in Volatile Health Sectors

This chapter focuses on investment strategies within the high-risk health care and biotech industries, emphasizing patient investing during stock dips. Speakers analyze specific companies like Lilly, Amgen, and Bristol Myers, discussing their market performances and the importance of assessing future potentials and company pipelines.